| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/02/2007 | US7157461 For therapy of hypertension |
| 01/02/2007 | US7157460 Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors |
| 01/02/2007 | US7157459 Oral administration of UFT (a combination of tegafur and uracil at a ratio of 1:4) to a postoperative lung cancer patient in need thereof for a period of at least about two years |
| 01/02/2007 | US7157458 Bifunctional energy-reversible acyl-compositions |
| 01/02/2007 | US7157457 Compounds useful in the treatment of inflammatory diseases |
| 01/02/2007 | US7157456 Anticoagulates for treating cardiovascular disorders, such as myocardial infarct, angina pectoris, restenoses after angioplasty, bypass, stroke; treatment of atherosclerosis, arthritis, Alzheimer's disease or cancer |
| 01/02/2007 | US7157455 4-Aminopyrimidine-5-one derivatives |
| 01/02/2007 | US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2007 | US7157453 Urea substituted imidazoquinolines |
| 01/02/2007 | US7157452 Substituted 4,9-dihydrocyclopenta{imn}phenanthridine-5-ones derivatives thereof and their uses |
| 01/02/2007 | US7157451 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine |
| 01/02/2007 | US7157450 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 01/02/2007 | US7157449 Use of an inhibitor of CTP synthetase, such as a glutamine analogue, and a substance use of an inhibitor of CTP synthetase, such as a glutamine analogue, and a substance capable of suppressing toxic effects in the manufacture of |
| 01/02/2007 | US7157448 Acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same |
| 01/02/2007 | US7157447 Useful for treating HIV infection and AIDS |
| 01/02/2007 | US7157446 Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol |
| 01/02/2007 | US7157445 Administration of enoxaparin sodium to patients with severe renal impairment |
| 01/02/2007 | US7157444 Aminosalicylate derivatives for treatment of inflammatory bowel disease |
| 01/02/2007 | US7157443 High molecular weight intracellular adhesin antigen; induction immunology response |
| 01/02/2007 | US7157442 Antibacterial compound |
| 01/02/2007 | US7157441 Administering an anti-virally effective amount of 1', 2' or 3'-modified nucleoside for therapy of hepatitis C virus infection |
| 01/02/2007 | US7157440 Partial and full agonists of A1 adenosine receptors |
| 01/02/2007 | US7157439 a cellulose and a HoxB3 homeotic nucleic acid or protein; improved neovascularization |
| 01/02/2007 | US7157437 Administering polynucleotide comprising an immunostimulatory sequence (ISS) to an individual exposed to herpes simplex virus, wherein the ISS comprises the sequence 5'-C, G-3', wherein the polynucleotide comprises a phosphate backbone modification, wherein the polynucleotide is greater than 6 nucleotides |
| 01/02/2007 | US7157436 An specific oligonucleotide sequence conataining 2-20 base 3'OH, 5'OH synthetic oligonucleotide which induces a response selected from cell cycle arrest, inhibition of cell proliferation, activation of caspases in cancer cells |
| 01/02/2007 | US7157434 Nucleoside compounds for treating viral infections |
| 01/02/2007 | US7157433 Compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
| 01/02/2007 | US7157432 Tetraphenylbacteriochlorin derivatives and compositions containing the same |
| 01/02/2007 | US7157431 Compositions of plant carbohydrates as dietary supplements |
| 01/02/2007 | US7157429 Method of regulating glucose metabolism, and reagents related thereto |
| 01/02/2007 | US7157425 Apolipoprotein agonist for use in the treatment of dyslipidemia |
| 01/02/2007 | US7157424 mistures of quinolinyloxy-substituted cyclic peptides containing fused cyclopropyl and pyrrolidine rings, an amine (especially tris(hydroxymethyl)aminomethane) and a base that inhibit hepatitis C viral protease |
| 01/02/2007 | US7157423 Using fumaric acid mono- and diamides, or monoamido fumaric acid monoesters for therapy of an autoimmune disease; transplantation medicine; therapy of mitochondrial diseases, for therapy of NF-kappaB mediated diseases |
| 01/02/2007 | US7157420 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 01/02/2007 | US7157408 5,7-Dibromo-8-(2-hydroxyethyl) quinoline and 5,7-dibromo-8-(2-methoxycarbonyloxyethyl) quinoline, for treating plant diseases |
| 01/02/2007 | US7157255 Stereoselective; reduction and esterification (in either order) of 2,3-dihydroxybutyrylalkanoic acid ester in the presence of a lipase or hydrolase, preferably of microorganism origin |
| 01/02/2007 | US7157248 Anticonvulsants; anxiolytic agents; multiple sclerosis; isolated nucleic acids; analyzing sample; calibration |
| 01/02/2007 | US7157243 DNA encoding mammalian T-type calcium channels |
| 01/02/2007 | US7157240 MID 4460, a human tyrosine phosphatase family member and uses therefor |
| 01/02/2007 | US7157226 probes, vectors and kits; sequences from the Core/E1 region of HCV type 3; detection of HCV infection |
| 01/02/2007 | US7157101 Micronized eplerenone compositions |
| 01/02/2007 | US7157099 Stable, biologically compatible pharmaceutical compositions in the form of water-in-oil microemulsions (w/o), for the sustained release by parenteral administration of active ingredients which are hydrophilic or are made hydrophilic by |
| 01/02/2007 | US7157097 Transdermal or topical mixtures of drugs such as hormones, gelling agents and oleic acid, alcohols or glycols as pentration intensifiers; drug delivery |
| 01/02/2007 | US7157092 3-(3-dodecanoyloxytetradecanoylamino) 9-(3-hydroxytetradecanoylamino)-4-oxo-5-azadecan-1,10-diol, 1,10-bis-(dihydrogenphosphate) or its addition salts; treatment of diseases related to a deficiency in the immune defense system or an overexpression of immune responses, cancer therapy |
| 01/02/2007 | US7157087 Modifying selected antibodies with biotin and streptavidin, conjugating these antibodies with an effector molecule, and delivering the conjugated effector to an intracellular target |
| 01/02/2007 | US7157080 Injectable hyaluronic acid derivative with pharmaceuticals/cells |
| 01/02/2007 | US7157079 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| 01/02/2007 | US7156881 Counteracting bioprosthetic calcification |
| 01/02/2007 | CA2445677C Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides |
| 01/02/2007 | CA2417800C Novel microemulsion and micelle systems for solubilizing drugs |
| 01/02/2007 | CA2412170C Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same |
| 01/02/2007 | CA2400578C Controlled-release compositions containing opioid agonist and antagonist |
| 01/02/2007 | CA2400226C Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 01/02/2007 | CA2376668C Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 01/02/2007 | CA2373999C Pyrazinone thrombin inhibitors |
| 01/02/2007 | CA2371550C Ziprasidone suspension |
| 01/02/2007 | CA2368615C Thiadiazolyl urea or thiourea derivatives for antiviral treatment |
| 01/02/2007 | CA2365495C Viral treatment |
| 01/02/2007 | CA2352361C Pharmaceutical combination preparations of carvedilol and hydrochlorothiazide and the process for their preparation |
| 01/02/2007 | CA2344350C 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines |
| 01/02/2007 | CA2339991C Microemulsions as solid dosage forms for oral administration |
| 01/02/2007 | CA2328320C Encapsulated long chain alcohols |
| 01/02/2007 | CA2315909C Novel acronycine derivatives, preparation method and pharmaceutical compositions |
| 01/02/2007 | CA2299511C A pharmaceutical composition having two coating layers |
| 01/02/2007 | CA2290538C Composition comprising finely divided, crystalline particles of budesonide |
| 01/02/2007 | CA2289817C 2-amino-4-alkylamino-3-pyrimidine oxides as soothing agents |
| 01/02/2007 | CA2283408C Swallow tablet comprising paracetamol |
| 01/02/2007 | CA2283255C Use of r-nsaid's for the prevention of alzheimer's disease |
| 01/02/2007 | CA2274464C Ketobenzamides as calpain inhibitors |
| 01/02/2007 | CA2261098C Novel erythromycin derivatives, method for preparing same and use thereof as drugs |
| 01/02/2007 | CA2237059C Targeted adenovirus vectors |
| 01/02/2007 | CA2236691C Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters |
| 01/02/2007 | CA2235996C New compounds and their compositions having anti-inflammatory and anti-thrombotic activities |
| 01/02/2007 | CA2225628C Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors |
| 01/02/2007 | CA2218892C Diaromatic propynyl or dienyl compounds |
| 01/02/2007 | CA2214899C Process for glucan preparation and therapeutic uses of glucan |
| 01/02/2007 | CA2211839C Use of melatonin for treating patients suffering from drug addiction |
| 01/02/2007 | CA2208129C Process for the preparation of chiral, nonracemic (4-aryl-2, 5-dioxoimidazo-lidin-1-yl)acetic acids |
| 01/02/2007 | CA2191454C Phosphinic acid derivatives and their use as endothelin converting enzyme inhibitors |
| 01/02/2007 | CA2177602C N-substituted azabicycloalkane derivatives, their preparation and use |
| 01/02/2007 | CA2168850C Estrogenic compounds as anti-mitotic agents |
| 01/02/2007 | CA2153419C Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 01/02/2007 | CA2135709C Melatonin derivatives for use in treating sleep disorders |
| 01/01/2007 | CA2550959A1 Methods for relaxation of smooth muscle contractions using trospium |
| 12/29/2006 | CA2551279A1 Use of biocompatible amphiphilic polymers as an anti-inflammatory agent |
| 12/28/2006 | WO2006138734A1 Triazolopyrimidine cannabinoid receptor 1 antagonists |
| 12/28/2006 | WO2006138715A1 Estrogen compositions for vaginal administration |
| 12/28/2006 | WO2006138695A1 Triazolopyridine derivatives as cannabinoid receptor 1 antagonists |
| 12/28/2006 | WO2006138686A1 Estrogen compositions for vaginal administration |
| 12/28/2006 | WO2006138682A1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 12/28/2006 | WO2006138657A1 Bicyclic heterocycles as cannabinoid-1 receptor modulators |
| 12/28/2006 | WO2006138656A2 Bicyclic heterocycles as cannabinoid-1 receptor modulators |
| 12/28/2006 | WO2006138641A2 Manufacturing process for tigecycline |
| 12/28/2006 | WO2006138609A2 Treatment of inflammatory conditions |
| 12/28/2006 | WO2006138608A2 Pharmaceutical compositions and use thereof |
| 12/28/2006 | WO2006138604A1 Hexahydro-pyrrolo-isoquinoline compounds for the treatment of cns disorders |
| 12/28/2006 | WO2006138590A1 Inhibition of osteolytic lesions by src kinase inhibitors |
| 12/28/2006 | WO2006138589A2 Opioid receptor ligands |
| 12/28/2006 | WO2006138549A1 Tricyclic compounds useful as serotonin inhibitors and 5-ht1a agonists and antagonists |
| 12/28/2006 | WO2006138534A2 Stable warfarin sodium liquid formulation and method of making same |